Product correctly added to cart.

discount label
Repaglinide C
View 3D

Biosynth logo

Repaglinide C

CAS: 1803084-79-8

Ref. 3D-DXC08479

1mgTo inquire
5mgTo inquire
10mgTo inquire
25mgTo inquire
50mgTo inquire
Estimated delivery in United States, on Wednesday 8 Jan 2025

Product Information

Name:
Repaglinide C
Description:

Repaglinide C is a medicinal compound that has been shown to be a potent inhibitor of human protein kinases. It has demonstrated anticancer activity in Chinese hamster ovary and human cancer cell lines, inducing apoptosis and inhibiting tumor growth. Repaglinide C is an analog of the kinase inhibitor staurosporine, which is known for its broad-spectrum activity against various kinases. Repaglinide C has been found to have a high potency against several kinases involved in cancer cell signaling pathways, making it a promising candidate for cancer therapy. This compound has also been detected in human urine samples, suggesting potential use as a biomarker for monitoring kinase inhibitor therapy.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
486.6 g/mol
Formula:
C30H34N2O4
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-DXC08479 Repaglinide C

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".